ui.skipToMain
Comercializadora de Servicios Médicos Cubanos, S.A.SMC Salud

Melagenina Plus® · Placental Histotherapy · Repigmentation

Vitiligo Treatment in Cuba

Vitiligo · Localized Vitiligo · Generalized Vitiligo

Cuba's Placental Histotherapy Center (Centro de Histoterapia Placentaria) in Havana developed Melagenina Plus, a placental-derived therapy for vitiligo that has attracted patients from over 50 countries. The treatment stimulates melanocyte replication and repigmentation through topical application combined with controlled sun exposure, offering a unique approach unavailable in most countries.

Vitiligo treatment in Cuba

Vitiligo — Treatment Video

Cuba's Placental Histotherapy for Vitiligo

Visual Guide

Understanding vitiligo care in Cuba

See the specialized facilities and patient-centered care that define our vitiligo treatment programs.

Specialized Dermatology care in Cuba

Specialized Dermatology care in Cuba

Comprehensive international patient coordination in Havana

Comprehensive international patient coordination in Havana

Clinical Evidence & Outcomes

The science behind vitiligo treatment in Cuba

Our clinical programs are grounded in peer-reviewed research and coordinated with Cuba's biotechnology institutions. Individual results vary and are confirmed during personalized evaluation.

Medically reviewed by
SMC Salud Office of Medical Affairs·Dermatology·Reviewed August 7, 2026

Melagenina Plus®

Vitiligo

50+countries served

Melagenina Plus is a placental-derived therapy developed by Cuba's Placental Histotherapy Center. It has been used by patients from over 50 countries seeking repigmentation treatment. The therapy works by stimulating melanocyte replication in depigmented skin areas when combined with controlled sun exposure.

Source: Centro de Histoterapia Placentaria — Havana

Placental Histotherapy

Dermatological Conditions

1987center founded — 35+ years

The Placental Histotherapy Center was established in 1987 and has become a reference institution for placental-derived therapies. Its research into the regenerative properties of placental extracts has produced treatments for vitiligo and other dermatological conditions.

Source: Centro de Histoterapia Placentaria — Havana

Outpatient Treatment Model

International Patients

2–3 wkstypical treatment duration

Treatment is administered on an outpatient basis with daily clinic visits over a 2–3 week period. Patients receive Melagenina Plus topical applications combined with controlled sun exposure, with progress monitored by dermatologists throughout the program.

Source: SMC Salud — Office of Medical Affairs

Outcomes shown reflect published clinical data and aggregate results. Individual results vary based on diagnosis, disease stage, and overall health, and are confirmed during a personalized medical evaluation. This page is for educational purposes and is not a substitute for professional medical advice.

Your Treatment Pathway

Vitiligo Care Pathway

A coordinated, step-by-step pathway from pre-travel preparation through treatment in Cuba and post-departure follow-up.

Pre-Travel
1

Initial Inquiry & Records Review

Week 1

Submit your medical records for expert review by our specialist team. Our international coordinators respond within 24–48 hours with an initial assessment.

  • Medical records submission via secure portal
  • Case review by specialist medical team
  • Initial eligibility assessment
2

Remote Medical Evaluation

Week 1–2

Your case is reviewed by the Cuban medical team. Additional tests or imaging may be requested remotely. A personalized treatment plan is developed and shared with you and your home-country physician.

  • Specialist remote consultation
  • Additional diagnostics if needed
  • Personalized treatment plan issued
3

Program Issuance & Travel Arrangements

Week 2–3

SMC Salud issues your official medical program letter. Our coordinators assist with visa application, flight booking, and accommodation — matched to your treatment program and family needs.

  • Medical program letter issued
  • Visa application support
  • Flight & accommodation arranged
In Cuba
4

Melagenina Plus Treatment Program

2–3 weeks

Dermatological evaluation of vitiligo type, extent (BSA involvement), and stability. Daily clinic visits for Melagenina Plus topical application combined with medically supervised controlled sun exposure.

  • Dermatological evaluation & BSA mapping
  • Daily Melagenina Plus application
  • Medically supervised sun exposure
5

Repigmentation Monitoring

Ongoing

Photographic tracking of repigmentation progress. Psychological support for the emotional impact of vitiligo. Sun exposure guidelines and maintenance protocols provided for continued care after return home.

  • Photographic repigmentation tracking
  • Psychological & quality-of-life support
  • Maintenance & sun exposure guidelines
Post-Departure
6

Discharge, Report & Follow-up

Final days + ongoing

Comprehensive medical report translated into your language. Take-home medication supply provided. Telemedicine follow-up program arranged so your Cuban medical team stays connected after you return home.

  • Translated comprehensive medical report
  • Take-home medication supply
  • Telemedicine follow-up scheduled

Our Comprehensive Approach

Melagenina Plus®

A placental-derived extract applied topically to depigmented areas to stimulate melanocyte activity and repigmentation.

Controlled Sun Exposure

Treatment is combined with medically supervised sun exposure to activate the melanin-stimulating properties of the therapy.

Comprehensive Evaluation

Dermatological assessment of vitiligo type, extent (BSA involvement), stability, and treatment history before starting.

Outpatient Protocol

Treatment is administered on an outpatient basis with daily clinic visits, allowing patients to enjoy Havana between sessions.

Psychological Support

Counseling and support for the emotional impact of vitiligo, addressing quality of life and self-image.

International Coordination

Medical visa, accommodation, interpretation, and 24/7 support throughout the treatment program.

Vitiligo — Treatment & Medication

Treatment Options Available in Cuba

Cuba's Placental Histotherapy Center developed Melagenina Plus®, a placental-derived therapy applied topically to depigmented areas to stimulate melanocyte activity, combined with controlled sun exposure. No therapy can cure vitiligo, and not every patient will benefit. Treatment suitability is determined after a dermatological evaluation of vitiligo type, extent, and stability.

Treatment suitability is determined after medical evaluation. No therapeutic outcome is guaranteed, and not every patient will benefit. Each case is reviewed individually by the medical team.

Vitiligo — Required Documents

Documents for Medical Evaluation

Providing these documents helps our medical team review your case before you travel. You do not need to send every document to begin — send what you have available.

Skin Photographs

Clear images of depigmented areas

Dermatology Reports

Specialist assessment and diagnosis

Previous Treatment Records

Prior therapies and their outcomes

Current Medications

All medications and topical treatments used

Recent Laboratory Results

Blood work and relevant test results

Diagnosis Reports

Confirmed vitiligo diagnosis and type

Send Your Medical Documents

Clinical Evidence

Patient Safety

Expert Specialists

International Standards

Frequently Asked Questions

Questions from international patients

Melagenina Plus is a placental-derived extract developed by Cuba's Placental Histotherapy Center. It is applied topically to depigmented skin areas to stimulate melanocyte activity and promote repigmentation. The treatment is combined with controlled sun exposure, which activates the melanin-stimulating properties of the placental extract. It was developed in Cuba and is not widely available in other countries.

Could This Treatment Be Right for You?

Submit your medical records for review by our medical team. We will assess your case and provide a personalized recommendation. Treatment suitability is determined only after medical evaluation.